Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus

Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus

Show other versions (1)

<h4>Aims</h4> Inflammatory osteolysis is sine-qua-non of active Charcot neuroarthropathy (CN) causing decreased foot bone mineral density (BMD) and fractures. We aimed to explore the effect of anti-inflammatory or anti-resorptive agents for effect on foot bone mineral content (BMC) and c...

Full description

Bibliographic Details
Main Authors: Liza Das, Ashu Rastogi, Edward B. Jude, Mahesh Prakash, Pinaki Dutta, Anil Bhansali
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575293/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575293/?tool=EBI

Similar Items